Short answer: No, California has not legalized psilocybin services statewide.

Senate Bill 58 was vetoed in 2023, so there is no licensed psilocybin therapy program in California today. Some cities, including Oakland and San Francisco, adopted lowest-enforcement-priority resolutions for certain plant and fungal entheogens. That is not the same as legalization or licensed clinics. If you want licensed psilocybin services, people typically travel to Oregon or regulated options in Colorado and verify providers on state pages before booking. See the Governor’s veto and local resolutions for the current picture. Veto letter · SF resolution

Short answer: Medical ketamine statewide and esketamine in REMS-certified programs.

Clinicians in California can prescribe ketamine, an FDA-approved anesthetic used off-label for mental-health conditions. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and must be administered in REMS-certified sites with monitoring. Expect a medical intake, screening for medications and conditions, supervised dosing, and integration support. Coverage for esketamine depends on your plan, while off-label ketamine is often self-pay. If psilocybin is your goal, most people compare ketamine locally with traveling to Oregon/Colorado for licensed services. SPRAVATO REMS

Short answer: Yes—Oregon has licensed centers, and Colorado is regulating Natural Medicine services.

In Oregon, sessions occur at licensed service centers with trained facilitators and a required process of preparation, administration, and integration. Colorado is licensing Healing Centers and facilitators; always verify status on state sites. Plan for travel, lodging, and the number of visits recommended by the center. Many clients book preparation and post-session integration with us so their care feels continuous. Start here: Oregon access · CO Healing Centers

Short answer: Not FDA-approved as of September 2025; access is mainly through clinical trials.

The FDA declined approval in 2024 and publicly released the Complete Response Letter in 2025, so MDMA-assisted therapy is not an approved treatment at this time. If you are exploring this route, most people look for actively recruiting studies and review eligibility, time commitment, and risks in plain language before applying. We can help you understand what participation typically entails and how to plan integration around study requirements. Overview: FDA CRL made public

Short answer: It varies by pathway, number of sessions, and clinical support.

Costs depend on intake and screening, session length and frequency, route of administration, medical monitoring, therapy time, and integration visits. Off-label ketamine is often self-pay; esketamine is billed through REMS-certified sites and may be covered depending on your plan. Licensed psilocybin services in Oregon/Colorado are paid to the center and include preparation and integration; travel and lodging are additional. We help you compare total program costs and consider HSA/FSA eligibility where applicable. Our Pricing page includes more information about pricing.

Short answer: Yes—education, safety, and integration support; we do not broker illegal activity.

Underground and ceremonial settings exist, but laws and safety practices vary. We do not sell or supply substances, we do not instruct on obtaining them, and we do not connect clients to distributors. What we do provide is objective education about legal context, rigorous safety screening guidance you can discuss with your clinician, a vetted question set for evaluating facilitators, and a preparation and integration plan tailored to your needs.

Short answer: Training, screening, supervision, ethics, and integration.

Ask about credentials and scope of practice; medical and psychological screening; supervision during sessions; boundaries, consent, and chaperone policies; emergency plans; and integration support. Clarify the number of sessions, total cost, cancellation policies, and what is included. In licensed settings, verify the center or facilitator on state sites; in community settings, request references and discuss consent and safety in detail. We can share our full vetting checklist during a concierge call. You can download a guide of questions to ask your facilitator prior to your experience Download the facilitator questions checklist.

Short answer: Yes—this depends on your history and medicines; always review with a clinician.

Common flags include certain heart conditions, seizure risk, uncontrolled hypertension, bipolar spectrum or psychosis risk, pregnancy, and untreated sleep apnea. Medications such as MAOIs, some SSRIs/SNRIs, stimulants, and blood-pressure drugs may require adjustments or may not be compatible with specific modalities. Licensed programs and ethical facilitators should screen carefully, coordinate with your prescriber, and build a monitoring plan. Our team helps you prepare the right questions for your medical providers.